Til forsiden

2009

Academic articles published by scientists affiliated with the Danish Dementia Research Centre in 2009 are presented below:
  • Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Hogenhaven H, Molbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen P, Christiansen M. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Neurobiol.Aging 2009; 30 (11):1834-41. pubmed-logo
  • Blahak C, Baezner H, Pantoni L, Poggesi A, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D, Hennerici MG. Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J.Neurol.Neurosurg. Psychiatry 2009; 80 (6):608-613. pubmed-logo
  • Boesgaard TW, Nielsen TT, Josefsen K, Hansen T, Jorgensen T, Pedersen O, Norremolle A, Nielsen JE, Hasholt L. Huntington's disease does not appear to increase the risk of diabetes mellitus. J.Neuroendocrinol. 2009; 21 (9):770-776. pubmed-logo 
  • Buerger K, Frisoni G, Uspenskaya O, Ewers M, Zetterberg H, Geroldi C, Binetti G, Johannsen P, Rossini PM, Wahlund LO, Vellas B, Blennow K, Hampel H. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI). Exp.Gerontol. 2009; 44 (9):579-585. pubmed-logo
  • Ellefsen B, Holm-Pedersen P, Morse DE, Schroll M, Andersen BB, Waldemar G. Assessing caries increments in elderly patients with and without dementia: a one-year follow-up study. J.Am.Dent.Assoc. 2009; 140 (11):1392-1400. pubmed-logo
  • Eskildsen SF, Ostergaard LR, Rodell AB, Ostergaard L, Nielsen JE, Isaacs AM, Johannsen P. Cortical volumes and atrophy rates in FTD-3 CHMP2B mutation carriers and related non-carriers. Neuroimage. 2009; 45 (3):713-721. pubmed-logo
  • Hasselbalch SG, Kampmann JP. Behandling af demenssygdomme - hvem skal behandles? Ugeskr.Laeger 2009; 171 (10):802-805. pubmed-logo
  • Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Pantoni L. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009; 339:b2477. pubmed-logo
  • Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, Gouw A, Scheltens P, Barkhof F, Visser MC, Fazekas F, Schmidt R, O'Brien J, Hennerici M, Baezner H, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T. MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc.Dis. 2009; 27 (4):336-344. pubmed-logo
  • Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, Scheltens P, Barkhof F, Visser MC, Fazekas F, Schmidt R, O'Brien J, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T. Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study. Cerebrovasc.Dis. 2009; 27 (4):384-391. pubmed-logo
  • Jones RW, Schwam E, Wilkinson D, Waldemar G, Feldman HH, Zhang R, Albert K, Schindler R. Rates of cognitive change in Alzheimer disease: Observations across a decade of placebo-controlled clinical trials with donepezil. Alzheimer Dis.Assoc.Disord. 2009; 23 (4):357-364. pubmed-logo

  • Lindquist SG, Schwartz M, Batbayli M, Waldemar G, Nielsen JE. Genetic testing in familial AD and FTD: mutation and phenotype spectrum in a Danish cohort. Clin.Genet. 2009; 76 (2):205-209. pubmed-logo
  • Nørremølle A, Budtz-Jorgensen E, Fenger K, Nielsen JE, Sorensen SA, Hasholt L. 4p16.3 haplotype modifying age at onset of Huntington disease. Clin.Genet. 2009; 75 (3):244-250. pubmed-logo
  • Phung TK, Andersen BB, Kessing LV, Mortensen PB, Waldemar G. Diagnostic evaluation of dementia in the secondary health care sector. Dement.Geriatr.Cogn Disord. 2009; 27 (6):534-542. pubmed-logo
  • Puschmann A, Ross OA, Vilarino-Guell C, Lincoln SJ, Kachergus JM, Cobb SA, Lindquist SG, Nielsen JE, Wszolek ZK, Farrer M, Widner H, van WD, Hagerstrom D, Markopoulou K, Chase BA, Nilsson K, Reimer J, Nilsson C. A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. Parkinsonism.Relat Disord. 2009; 15 (9):627-632. pubmed-logo
  • Rohrer JD, Ahsan RL, Isaacs AM, Nielsen JE, Ostergaard L, Scahill R, Warren JD, Rossor MN, Fox NC, Johannsen P. Presymptomatic generalized brain atrophy in frontotemporal dementia caused by CHMP2B mutation. Dement.Geriatr.Cogn Disord. 2009; 27 (2):182-186. pubmed-logo
  • Ropele S, Seewann A, Gouw AA, van der Flier WM, Schmidt R, Pantoni L, Inzitari D, Erkinjuntti T, Scheltens P, Wahlund LO, Waldemar G, Chabriat H, Ferro J, Hennerici M, O'Brien J, Wallin A, Langhorne P, Visser MC, Barkhof F, Fazekas F. Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) study. J.Magn Reson.Imaging 2009; 29 (2):268-274. pubmed-logo
  • Schüz J, Waldemar G, Olsen JH, Johansen C. Risiko for affektion af centralnervesystemet ved brug af mobiltelefon. Ugeskr.Laeger 2009; 171 (45):3268-3271.
  • Schuz J, Waldemar G, Olsen JH, Johansen C. Risks for central nervous system diseases among mobile phone subscribers: a Danish retrospective cohort study. PLoS.One. 2009; 4 (2):e4389. pubmed-logo

  • Schultz K, Wiehager S, Nilsson K, Nielsen JE, Lindquist SG, Hjermind LE, Andersen BB, Wallin A, Nilsson C, Petersen A. Reduced CSF CART in dementia with Lewy bodies. Neurosci.Lett. 2009; 453 (2):104-106. Se abstract her.

  • Stokholm J, Vogel A, Johannsen P, Waldemar G. Validation of the Danish Addenbrooke's Cognitive Examination as a screening test in a memory clinic. Dement.Geriatr.Cogn Disord. 2009; 27 (4):361-365. Se abstract her.

  • Svenstrup K, Bross P, Koefoed P, Hjermind LE, Eiberg H, Born AP, Vissing J, Gyllenborg J, Norremolle A, Hasholt L, Nielsen JE. Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia. J.Neurol.Sci. 2009; 284 (1-2):90-95. Se abstract her.

  • Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Waldemar G. Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial. BMC.Health Serv.Res. 2009; 9:215. Se abstract her.

  • Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund LO, Scheltens P, Waldemar G, Schrotter G, Ferro JM, Chabriat H, Bazner H, Visser M, Inzitari D, O'Brien JT. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol.Med. 2009; 1-8. Se abstract her.

  • Waldorff FB, Siersma V, Waldemar G. Association between subjective memory complaints and health care utilisation: a three-year follow up. BMC.Geriatr. 2009; 9:43. Se abstract her.

  • Waldorff FB, Siersma V, Waldemar G. Association between subjective memory complaints and nursing home placement: a four-year follow-up. Int.J.Geriatr.Psychiatry 2009; 24 (6):602-609. Se abstract her.

  • Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopez OL, Cummings J, Xu Y, Feldman HH. Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease. Dement.Geriatr.Cogn Disord. 2009; 28 (3):244-251. Se abstract her.
Senest opdateret: 31. March 2017